Hanmi R&D creates a better future for humanity.

Hanmi Pharmaceutical is a R&D-centric pharmaceutical company that focuses on developing new drugs for a better life for humanity. Hanmi Pharmaceutical is establishing and executing R&D strategies to create powerful, sustainable, and unprecedented innovations focusing on obesity/metabolism, oncology, and rare diseases with high unmet medical needs. Our current main pipeline includes long-acting new bio drugs and dual antibodies based on 'targeted protein control' and Hanmi's unique platform technology, 'LAPSCOVERY.' We also focus on developing FDCs and INDs to improve patient's quality of life. Hanmi Pharmaceutical is discovering new modalities such as 'ADC(antibody-drug conjugate), ' 'Cell/Gene Therapy,' 'mRNA-based Therapy,' and 'TPD(targeted protein degrader)' as next-generation technologies.